Evaluation of Safety and Pharmacokinetics of Administering Intravenous Busulfan in a Twice-daily or Daily Schedule to Patients with Advanced Hematologic Malignant Disease Undergoing Stem Cell Transplantation.

Hugo F Fernandez, Hai T Tran, Federico Albrecht, Shari Lennon, Humberto Caldera, Mark S Goodman

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBiology of Blood and Marrow Transplantation
Volume8
DOIs
StatePublished - Jan 9 2002

Disciplines

  • Medicine and Health Sciences
  • Endocrinology, Diabetes, and Metabolism
  • Immunology and Infectious Disease

Cite this